These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3209928)

  • 1. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation].
    Miyawaki Y; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adenocarcinoma in mice.
    Kimura J
    Cancer Res; 1978 Jan; 38(1):78-82. PubMed ID: 618585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of juvenile adenomatous hyperplasia of the endometrium by progesterone stimulation].
    Krafft W
    Zentralbl Gynakol; 1989; 111(12):846-8. PubMed ID: 2475003
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management and evolution of endometrial hyperplasia using small doses of progestational hormones].
    Calderón JJ; García G; Maqueo M
    Ginecol Obstet Mex; 1969 Mar; 25(149):311-7. PubMed ID: 4181037
    [No Abstract]   [Full Text] [Related]  

  • 5. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)].
    Beliaeva LA; Bukhvalov IB; Zheleznov BI; Raĭkhlin NT
    Arkh Patol; 1982; 44(4):18-25. PubMed ID: 7082195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of dysfunctional climacteric bleeding by Norbiogest (author's transl)].
    Knejzlíková I; Srácek J; Wolná E; Malík V
    Cesk Gynekol; 1974 Sep; 39(8):610-1. PubMed ID: 4434527
    [No Abstract]   [Full Text] [Related]  

  • 8. [Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
    Tkeshelashvili VT; Bokhman IaV; Vishnevskiĭ AS
    Vopr Onkol; 1984; 30(3):71-6. PubMed ID: 6201002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.
    Thom MH; White PJ; Williams RM; Sturdee DW; Paterson ME; Wade-Evans T; Studd JW
    Lancet; 1979 Sep; 2(8140):455-7. PubMed ID: 89511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the progestogen challenge test to reduce the risk of endometrial cancer.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM
    Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gestagen treatment of endometrial carcinoma].
    Seewald HJ; Böhm W
    Zentralbl Gynakol; 1974 Feb; 96(5):153-7. PubMed ID: 4133105
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancy following hormonal therapy for adenocarcinoma of the endometrium.
    O'Neill RT
    Am J Obstet Gynecol; 1970 Sep; 108(2):318-21. PubMed ID: 4952585
    [No Abstract]   [Full Text] [Related]  

  • 13. [The outlook for the management of endometrial hyperplasia. A preliminary report].
    Martínez-Meza MT; Sojo-Aranda I; Santiago-Payán H; González-Diddi M; Cortés-Gallegos V
    Ginecol Obstet Mex; 1987 Mar; 55():80-4. PubMed ID: 3154367
    [No Abstract]   [Full Text] [Related]  

  • 14. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
    Van Campenhout J; Choquette P; Vauclair R
    Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histological changes observed in the treatment of endometrial glandular epithelioma with lynestrenol].
    Lejeune B; Wilkin P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Dec; 6(8):1159-69. PubMed ID: 608932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic findings in endometrial hyperplasia.
    Kashimura M; Baba S; Shinohara M; Kashimura Y; Saito T; Hachisuga T
    Acta Cytol; 1988; 32(3):335-40. PubMed ID: 3376700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse endometrial effects of long-cycle estrogen and progestogen replacement therapy. The Scandinavian LongCycle Study Group.
    Cerin A; Heldaas K; Moeller B
    N Engl J Med; 1996 Mar; 334(10):668-9. PubMed ID: 8592546
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of high dosage progesterone therapy in carcinoma corporis uteri].
    Seewald HJ; Böhm W; Przesang R
    Zentralbl Gynakol; 1977; 99(7):392-5. PubMed ID: 868363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of estrogen-induced hyperplasia to endometrial carcinoma.
    Bhagavan BS; Parmley TH; Rosenshein NB; Jefferys JL; Grisso JA; Stolley PD
    Obstet Gynecol; 1984 Jul; 64(1):12-5. PubMed ID: 6738936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.